# EDGAR Filing Document

**Accession Number:** 0001961988
**File Stem:** 0001437749-23-001795
**Filing Date:** 2023-1
**Character Count:** 9370
**Document Hash:** 72f86a3d93b6828f10bcbdd1180d1092
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-23-001795.hdr.sgml**: 20230125

**ACCESSION NUMBER**: 0001437749-23-001795

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230116

**FILED AS OF DATE**: 20230125

**DATE AS OF CHANGE**: 20230125

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Bavaro Michael
- **CENTRAL INDEX KEY:** 0001961988

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-11993
- **FILM NUMBER:** 23553451

**MAIL ADDRESS:**
- **STREET 1:** 3000 LAKESIDE DRIVE
- **STREET 2:** SUITE 300N
- **CITY:** BANNOCKBURN
- **STATE:** IL
- **ZIP:** 60015
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Option Care Health, Inc.
- **CENTRAL INDEX KEY:** 0001014739
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HOME HEALTH CARE SERVICES [8082]
- **IRS NUMBER:** 050489664
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 3000 LAKESIDE DR
- **STREET 2:** SUITE 300N
- **CITY:** BANNOCKBURN
- **STATE:** IL
- **ZIP:** 60015
- **BUSINESS PHONE:** 312 940 2443

**MAIL ADDRESS:**
- **STREET 1:** 3000 LAKESIDE DR
- **STREET 2:** SUITE 300N
- **CITY:** BANNOCKBURN
- **STATE:** IL
- **ZIP:** 60015

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BioScrip, Inc.
- **DATE OF NAME CHANGE:** 20050314

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MIM CORP
- **DATE OF NAME CHANGE:** 19960516

## Ex-24

```

POWER OF ATTORNEY
FOR SECTION 16 REPORTING OBLIGATIONS

       KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and
 appoints each of Michael Shapiro, Collin Smyser and Sarah Kim, signing singly,
 the undersigned's true and lawful attorney-in-fact to:

  (i)  execute for and on behalf of the undersigned, in the undersigned's
 capacity as an officer and/or director and/or owner of greater than 10% of the
 outstanding shares of common stock of Option Care Health, Inc., a Delaware
 corporation (the "Company"), Forms 3, 4 and 5 (including any amendments,
 supplements or exhibits thereto) in accordance with Section 16(a) of the
 Securities Exchange Act of 1934 and the rules thereunder;

  (ii)  do and perform any and all acts for and on behalf of the undersigned
 which may be necessary or desirable to complete and execute any such Form 3,
 4 or 5 (including any amendments, supplements or exhibits thereto) and timely
 file such form with the United States Securities and Exchange Commission (the
 "SEC") and any stock exchange or similar authority, including the New York
 Stock Exchange, and including without limitation the filing of a Form ID or
 any other documents necessary or appropriate to enable the undersigned to file
 the Form 3, 4 and 5 electronically with the SEC;

  (iii)  seek or obtain, as the undersigned's representative and on the
 undersigned's behalf, information on transactions in the Company's securities
 from any third party, including brokers, employee benefit plan administrators
 and trustees, and the undersigned hereby authorizes any such person to release
 any such information to each of the undersigned's attorneys-in-fact appointed
 by this Power of Attorney and ratifies any such release of information; and

   (iv)  take any other action of any type whatsoever in connection with the
 foregoing which, in the opinion of such attorney-in-fact, may be of benefit
 to, in the best interest of, or legally required by, the undersigned, it being
 understood that the documents executed by such attorney-in-fact on behalf of
 the undersigned pursuant to this Power of Attorney shall be in such form and
 shall contain such terms and conditions as such attorney-in-fact may approve
 in such attorney-in-fact's discretion.

       The undersigned hereby grants to each such attorney-in-fact full power
 and authority to do and perform any and every act and thing whatsoever
 requisite, necessary or proper to be done in the exercise of any of the rights
 and powers herein granted, as fully to all intents and purposes as the
 undersigned might or could do if personally present, with full power of
 substitution or revocation, hereby ratifying and confirming all that such
 attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
 lawfully do or cause to be done by virtue of this power of attorney and the
 rights and powers herein granted.

       The undersigned acknowledges that the foregoing attorneys-in-fact, in
 serving in such capacity at the request of the undersigned, are not assuming,
 nor is the Company assuming, any of the undersigned's responsibilities to
 comply with Section 16 of the Securities Exchange Act of 1934.

       This Power of Attorney shall remain in full force and effect until the
 undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
 undersigned's holdings of and transactions in securities issued by the Company,
 unless earlier revoked by the undersigned in a signed writing delivered to the
 foregoing attorneys-in-fact.

       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
 be executed as of date first written above.

Signed and acknowledged:

/s/ Michael Bavaro

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Bavaro Michael<br><sub>(Last) (First) (Middle)</sub><br>C/O OPTION CARE HEALTH, INC.<br>3000 LAKESIDE DRIVE, SUITE 300N<br><sub>(Street)</sub><br>BANNOCKBURN, IL 60015<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Option Care Health, Inc. [ OPCH ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2023-01-16 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Chief Human Resources Officer_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 10047<sup>(1)</sup> | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Employee Stock Option (right to buy) | <sup>(2)</sup> | 2032-02-17 | Common Stock | 8612 | $23.9600 | D |  |
| Employee Stock Option (right to buy) | 2024-10-21 | 2031-10-21 | Common Stock | 8974 | $25.7500 | D |  |
| Employee Stock Option (right to buy) | <sup>(3)</sup> | 2031-02-23 | Common Stock | 4904 | $18.9700 | D |  |

---

### Footnotes:

(1) Includes (i) 4,436 restricted stock units that vest as to 25% of the underlying shares of Common Stock on each of February 17, 2023, February 17, 2024, February 17, 2025 and February 17, 2026, (ii) 2,504 restricted stock units that vest as to 50% of the underlying shares of Common Stock on each of February 23, 2023, and 25% of the underlying shares of Common Stock on each of February 23, 2024 and February 23, 2025., and (iii) 3,107 restricted stock units that vest on October 21, 2024.

(2) Stock options that vest as to 25% of the underlying shares of Common Stock on each of February 17, 2023, February 17, 2024, February 17, 2025 and February 17, 2026.

(3) Stock options that vest as to 50% of the underlying shares of Common Stock on February 23, 2023, and 25% of the underlying shares of Common Stock on each of February 23, 2024 and February 23, 2025.

**Signature:** /s/ Collin Smyser, attorney-in-fact for Mr. Bavaro  
**Date:** 2023-01-25

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**